PG Options Signal Calm Before the Storm: Thorne Acquisition Fuels Bullish Bias Amid Consolidation

• P&G trades at $146.175, dipping slightly from yesterday’s close as the market digests the massive $3.8B Thorne acquisition news.
• Options flow shows a distinct bullish tilt, with Call Open Interest significantly outpacing Puts (0.63 ratio), suggesting traders are positioning for upside.
• Technicals indicate a short-term bullish engulfing pattern, though long-term trends remain range-bound between $143 and $151.
• Key resistance sits near $148.50, while support holds firmly around $145.40, creating a tight trading range for today.

It’s one of those days where the headline screams growth, but the price action whispers caution. Procter & Gamble is sitting at $146.175 today, down about 1.24% from yesterday’s close. If you’re watching the screen, you might feel a bit of whiplash. The news from yesterday is huge—a $3.8 billion acquisition of Thorne to boost their healthcare portfolio—but the stock is consolidating. It’s not ignoring the news; it’s digesting it. And that’s actually a good sign for the bulls, provided they pay attention to where the big money is hiding in the options chain.

Where the Smart Money Is Betting

Let’s look under the hood at the options activity, because that’s where the real story lives. The Put/Call Open Interest ratio is sitting at a healthy 0.63. In plain English? There are way more calls than puts. Traders aren’t hedging against a crash; they’re betting on a rise.

For this Friday’s expiration, the heaviest Open Interest for calls is clustered at the $155 and $146 strikes. The $155 strike has nearly 3,800 contracts. That’s a significant ceiling. It acts as a magnet and a resistance wall. Meanwhile, the $146 strike with over 1,600 contracts is right near our current price, acting as immediate support. On the put side, the biggest bets are at $139 and $142, with 1,122 and 811 contracts respectively. These are deep out-of-the-money puts. The market isn’t expecting a freefall. It’s pricing in a controlled move upward, with a safety net well below current levels.

Looking ahead to next Friday, the bullish sentiment continues. The $152.50 call has over 2,000 contracts, and the $160 call has 533. The $140 put has 905 contracts. This distribution tells me that institutional players expect PG to grind higher over the next two weeks. They see $152.50 as a realistic target and $140 as a floor. There were no significant whale block trades today, which means this isn’t a panic sell-off or a sudden insider dump. It’s a steady, calculated accumulation.

The Thorne Catalyst

You can’t talk about PG right now without mentioning the Thorne deal. Announced yesterday, this $3.8 billion acquisition is a strategic pivot into the high-growth, high-margin wellness sector. CEO Shailesh Jejurikar called it a "good price for the growth rates," and analysts are largely agreeing. The consensus price target is around $160.13, which implies nearly 9% upside from here.

This news supports the options data. If the market believed the deal was overpriced or risky, we’d see a spike in put buying. Instead, we see call buying. The narrative is shifting from "mature consumer staples" to "growth-driven healthcare." The integration of Thorne’s AI-powered wellness advisor, Taia, adds a tech-forward element that appeals to modern investors. However, there’s always execution risk. Integrating a science-focused brand like Thorne into P&G’s mass-market machine is tricky. But for now, the sentiment is overwhelmingly positive.

Actionable Trade Ideas for Today

So, how do we trade this? The stock is in a narrow range between $145.38 (intraday low) and $146.89 (intraday high). The 30-day moving average is at $148.28, which is our near-term resistance. The 200-day MA is at $148.03. Both converge around $148, making that level critical.

For the stock:

• Entry: Consider buying shares near $145.50 if support holds. This aligns with the intraday low and the psychological support level.
• Target: Look for a move toward $148.50 to test the resistance zone. A break above this could open the door to $152.
• Stop Loss: Place a tight stop below $143.88, which is the lower Bollinger Band. If it breaks that, the short-term bullish trend is invalid.

For options:

• Bullish Play: Buy the PG20260814C152.5. With 2,007 contracts open interest, this strike is heavily watched. It offers a good risk/reward profile if PG drifts higher over the next week. It’s cheaper than the front-month options and benefits from the upcoming expiration of uncertainty.
• Aggressive Play: If you believe the $160 analyst target is within reach soon, consider the PG20260814C160. It’s OTM but has strong open interest (533 contracts), suggesting institutional interest in a breakout.
• Hedge: If you’re worried about a pullback, the PG20260807P142 offers protection. With 811 contracts open, it’s a liquid hedge if the stock dips below $143.

Volatility on the Horizon

The RSI is at 49.9, which is neutral, but the MACD histogram is negative, suggesting momentum is still catching up. The short-term bullish engulfing pattern is a good sign, but we need volume to confirm the move. Today’s volume of 1.18 million shares is decent but not explosive.

I see a bullish trend ahead, but it won’t be a vertical rocket. It’ll be a grind. The options market is telling us that traders expect higher prices, specifically targeting $152 to $155 over the next two weeks. The Thorne acquisition provides the fuel, and the technicals provide the map. Just keep an eye on that $148 resistance level. If PG clears that with volume, the sky’s the limit. If not, expect another week of range-bound trading. Stay patient, trade the levels, and let the options data guide your hand.